97 related articles for article (PubMed ID: 1537778)
1. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
Simeon JG; Ferguson HB; Knott V; Roberts N; Gauthier B; Dubois C; Wiggins D
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):29-33. PubMed ID: 1537778
[TBL] [Abstract][Full Text] [Related]
2. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Udelman HD; Udelman DL
J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
Ropert R; Bernes J; Dachary JM
Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
[TBL] [Abstract][Full Text] [Related]
4. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
5. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam in the treatment of neurotic anxiety.
Kerry RJ; McDermott CM
Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam treatment of avoidant personality traits in social phobic patients.
Reich J; Noyes R; Yates W
J Clin Psychiatry; 1989 Mar; 50(3):91-5. PubMed ID: 2925598
[TBL] [Abstract][Full Text] [Related]
8. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Cohn JB
J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
[TBL] [Abstract][Full Text] [Related]
9. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
Pecknold J; Luthe L; Munjack D; Alexander P
J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
12. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
[TBL] [Abstract][Full Text] [Related]
13. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Kolin IS; Linet OI
J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam in clinically anxious patients with depressed mood.
Aden GC
J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
[TBL] [Abstract][Full Text] [Related]
16. Alprazolam effects in children with anxiety disorders.
Simeon JG; Ferguson HB
Can J Psychiatry; 1987 Oct; 32(7):570-4. PubMed ID: 3315169
[TBL] [Abstract][Full Text] [Related]
17. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam and diazepam in the treatment of generalized anxiety.
Elie R; Lamontagne Y
J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
De Candia MP; Di Sciascio G; Durbano F; Mencacci C; Rubiera M; Aguglia E; Garavini A; Bersani G; Di Sotto A; Placidi G; Cesana BM
Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
[TBL] [Abstract][Full Text] [Related]
20. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]